[1] Liu Y, Du H, Wang Y, et al. Osteoprotegerin-knockout mice developed early onset root resorption [J].J Endod, 2016, 42(10):1516-1522.
[2] Albaker BK, Wong RW. Diagnosis and management of root resorption by erupting canines using cone-beam computed tomography and fixed palatal appliance:a case report [J]. J Med Case Rep, 2010, 4:399.doi:10.1186/1752-1947-4399.
[3] Gama A, Navet B, Vargas JW, et al. Bone resorption:an actor of dental and periodontal development[J]. Front Physiol, 2015, 6:510-517.
[4] Liu YK, Ye J, Han QL, et al. Toxicity and bioactivity of cobalt nanoparticles on the monocytes[J]. Orthop Surg, 2015, 7(2):168-173.
[5] Wada T, Nakashima T, Hiroshi N, et al. RANKL-RANK signaling in osteoclastogenesis and bone disease[J]. Trends Mol Med, 2006, 12(1):17-25.
[6] 陶渊博, 邢雅丽, 方芝娟, 等. 生物活性物质熊果酸资源分布状况研究进展[J]. 林产化学与工业, 2012, 32(1):119-126.
[7] Wang X, Li L, Wang B, et al. Effects of ursolic acid on the proliferation and apoptosis of human ovarian cancer cells[J]. J Huazhong Univ Sci Technol Med Sci, 2009, 29(6):761-764.
[8] Chen H, Gao Y, Wang A, et al. Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents[J]. Eur J Med Chem, 2015, 92:648-655.
[9] Li X,Zhang H, Zheng D, et al. Efficient delivery of ursolic acid by poly (n-vinylpyrrolidone)-block-poly (ε-caprolactone) nanoparticles for inhibiting the growth of hepatocellular carcinoma in vitro and in vivo[J]. Int J Nanomed,2015, 10(1):1909-1920.
[10] Jia Y, Bhuiyan MJ, Jun HJ, et al. Ursolic acid is a PPAR-α agonist that regulates hepatic lipid metabolism[J]. Bioorg Med Chem Lett, 2011, 21(19):5876-5880.
[11] Weng H, Tan ZJ, Hu YP, et al. Ursolic acid induces cell cycle arrest and apoptosis of gallbladder carcinoma cells[J]. Cancer Cell Int, 2014, 14(1):96-106.
[12] Li J, Guo WJ, Yang QY. Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15[J]. World J Gastroenterol, 2002, 8(3):493-495.
[13] Pathak AK, Bhutani M, Nair AS, et al. Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells[J]. Mol Cancer Res, 2007, 5(9):943-955.
[14] Li Y, Lu X, Qi H, et al. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and suppression of ERK1/2 MAPK in heLa cells[J]. J Pharmacol Sci, 2014, 125(2):202-210.
[15] Murakami S, Takashima H, Sato-Watanabe M, et al. Ursolic acid, an antagonist for transforming growth factor (TGF)-β1[J]. FEBS Lett, 2004, 566(1-3):55-59.
[16] Checker R, Sandur SK, Sharma D, et al. Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-κB, AP-1 and NF-AT[J]. PLoS One, 2012, 7(2):e31318.
[17] Brezniak N, Wasserstein A. Root resorption after orthodontic treatment:Part 1. Literature review[J]. Am J Orthod Dentofacial Orthop, 1993, 103(1):62-66.
[18] 仲蕾蕾,杨 冰,黄晓斌,等. OPG/RANKL/RANK系统在成骨细胞和破骨细胞相互调节中的作用[J].中国骨质疏松杂志,2011,17(11):1010-1013.
[19] 董 伟,彭宏峰,梁永强,等.双膦酸盐对NFATc1及相关因子p-NF-κB、p-c-Jun在破骨细胞分化过程中的影响[J].解放军医学杂志,2015,40(10):778-781.
[20] Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis[J]. Nature, 1999, 397(6717):315-323.
[21] Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation[J]. Nature, 2003, 423(6937):337-342.
[22] Ferlin A, Pepe A, Facciolli A, et al. Relaxin stimulates osteoclast differentiation and activation[J]. Bone, 2010, 46(2):504-513.
[23] Tan H, Furuta S, Nagata T, et al. Inhibitory effects of the leaves of loquat (Eriobotrya japonica) on bone mineral density loss in ovariectomized mice and osteoclast differentiation[J]. J Agric Food chem, 2014, 62(4):836-841.
[24] Jiang C, Xiao F, Gu X, et al. Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-κB signaling[J]. Biochimie, 2015, 111:107-118.
[25] Lee SU, Park SJ, Kwak HB, et al. Anabolic activity of ursolic acid in bone:Stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo[J]. Pharmacol Res, 2008, 58(5/6):290-296. |